Antineoplastic drugs for oncology program
Original notice title
Medicamente Program Oncologie (Antineoplazice)
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
50 / 100
Risk factors
Detailed specifications, quantity requirements, and technical data for lots 2-6 are not available in the notice or anal...
The tender deadline in structured data (12:00 UTC) differs from XML notice (15:00 local time). This could cause confusi...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
We couldn't generate the AI analysis for this tender. Please try again later.
Buyer
Name
SPITALUL JUDETEAN DE URGENTA "SFANTA CHIRIACHI" VASLUI
Location
Vaslui, ROU
Website
Buyer profile
Identifier
3551942
Lots (6)
LOT-0001
CALCII FOLINAS -10mg/ml - SOL. INJ./PERF. 100mg
Calcium folinate injection solution 100mg, min. 10 vials, max. 600 vials per framework; largest subsequent contract value 236.6 RON.
RON 14.2k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
Cantitatea minima acord-cadru este 10 flacoane, Cantitatea maxima acord-cadru este 600 flacoane, Cantitatea minima contract subsecvent este 1 flacoane, Cantitatea maxima contract subsecvent este 10 flacoane, Valoarea celui mai mare contract subsecvent este 236.6 lei
LOT-0002
CALCII FOLINAS -10mg/ml - SOL. INJ./PERF. 200mg
Lot 2: antineoplastic agent (specific product not specified in structured data).
RON 85.9k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
Cantitatea minima acord-cadru este 10 flacoane, Cantitatea maxima acord-cadru este 600 flacoane, Cantitatea minima contract subsecvent este 1 flacoane, Cantitatea maxima contract subsecvent este 10 flacoane, Valoarea celui mai mare contract subsecvent este 1431.9 lei
LOT-0003
CALCII FOLINAS -10mg/ml - SOL. INJ./PERF. 350mg
Lot 3: antineoplastic agent (specific product not specified).
RON 138.9k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
Cantitatea minima acord-cadru este 10 flacoane, Cantitatea maxima acord-cadru este 600 flacoane, Cantitatea minima contract subsecvent este 1 flacoane, Cantitatea maxima contract subsecvent este 10 flacoane, Valoarea celui mai mare contract subsecvent este 2314.5 lei
LOT-0004
DURVALUMABUM - 50mg/ml - CONC. PT. SOL. PERF. 120mg
Cantitatea minima acord-cadru este 2 flacoane, Cantitatea maxima acord-cadru este 100 flacoane, Cantitatea minima contract subsecvent este 1 flacoane, Cantitatea maxima contract subsecvent este 2 flacoane, Valoarea celui mai mare contract subsecvent este 4134.4 lei
RON 206.7k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0005
TREMELIMUMABUM - 20mg/ml-CONC. PT. SOL. PERF. 300mg
Cantitatea minima acord-cadru este 2 flacoane, Cantitatea maxima acord-cadru este 20 flacoane, Cantitatea minima contract subsecvent este 1 flacoane, Cantitatea maxima contract subsecvent este 2 flacoane, Valoarea celui mai mare contract subsecvent este 180954.64 lei
RON 1.8M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
LOT-0006
AMIVANTAMABUM - 350mg - CONC. PT. SOL. PERF. 350mg
Cantitatea minima acord-cadru este 2 flacoane, Cantitatea maxima acord-cadru este 100 flacoane, Cantitatea minima contract subsecvent este 1 flacoane, Cantitatea maxima contract subsecvent este 2 flacoane, Valoarea celui mai mare contract subsecvent este 11887.72 lei
RON 594.4k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Framework maximum value
Procurement Details
- Publication date
- 14 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Romanian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 408425-2026
- Source notice ID
- 1508bcea-bffe-43e7-a61e-620b01115d08
Documents (2)
Similar tenders
Spain – Antibacterials for systemic use – Medicamentos con principios activos apremilast, nintedanib, eltrombopag, dalvabancina, pazopanib y asitinib
Romania – Various medicinal products – Furnizare diverse medicamente
Cyprus – Antineoplastic agents – Προσφορά για την προμήθεια Imetelstat- Αρ. Διαγ. Φ.Υ.Υ. 86/2026 (ΥΥ), Αρ. Φακ. Φ.Υ.Υ. 13.25.02.08.294-YY
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antineoplastic agents – Leki onkologiczne i sprzęt pomocniczy
Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
50 / 100
Risk factors
Detailed specifications, quantity requirements, and technical data for lots 2-6 are not available in the notice or anal...
The tender deadline in structured data (12:00 UTC) differs from XML notice (15:00 local time). This could cause confusi...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications